At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
prospective collection of surgical exudates (SEs)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
In Brief
An observational study evaluating prospective collection of surgical exudates (SEs) for GastroEsophageal Cancer. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this research is to collect surgical drain fluid and blood from patients who have undergone surgery for gastric or esophageal cancer, and to analyze the fluid and blood using a variety of laboratory techniques for molecular markers capable of predicting response to immunotherapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastroEsophageal Cancer
CountriesUnited States
CollaboratorsGeorge Mason University
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
First PostedApr 2022
Primary CompletionAug 2025
TodayJul 2026
First PostedApr 20, 2022
Enrollment StartJan 26, 2022
Primary CompletionAug 5, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 4.2 years ago
Interventions
prospective collection of surgical exudates (SEs)other
prospective collection of surgical exudates (SEs) from patients who are hospitalized for post-operative recovery from esophagectomy or gastrectomy for gastroesophageal cancer